Why Respiri, page-5

  1. 164 Posts.
    lightbulb Created with Sketch.  22
    Respiri’s monitoring asthma devices cannot be released to the market early enough!
    A recently published medical journal points to a high need for accurate monitoring devices!

    The conclusion (from med. journal) is, that asthma medicine has negative side effects for children - also only increasing the dose for children when symptoms increase, is not an effective treatment plan!

    http://www.nejm.org/doi/full/10.1056/NEJMoa1710988
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.